Skip to content

Clinical and Paraclinical Characteristics of the Systemic Scleroderma Cohort According to the Criteria ACR 2013 and the History of Professional Exposure or of Agricultural Environment

Clinical and Paraclinical Characteristics of the Systemic Scleroderma Cohort According to the Criteria ACR 2013 and the History of Professional Exposure or of Agricultural Environment

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT03262922
Acronym
PRESSY
Enrollment
327
Registered
2017-08-25
Start date
2016-07-29
Completion date
2022-02-18
Last updated
2022-04-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Systemic Scleroderma

Keywords

systemic scleroderma, environmental and professional toxics

Brief summary

The aim of the study is to compare the exposure to environmental and professional toxics by patients with systemic scleroderma and by patients not achieved by this pathology.

Detailed description

This study is based on a questionnaire. The data will be collected according a retrospective and prospective design : * at diagnostic of the disease * at the inclusion in the systemic scleroderma cohort * during the annual visit (in 2017-2018-2019-2020)

Interventions

None listed

Sponsors

Rennes University Hospital
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
OTHER

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Patients with systemic scleroderma

Exclusion criteria

\-

Design outcomes

Primary

MeasureTime frameDescription
Questionnaire to evaluate the exposition of environmental and professional toxicsonce a year up to 2020clinical, personal and professional data

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026